Bienville Capital Management »

Recursion Pharmaceuticals shares owned by Bienville Capital Management

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Bienville Capital Management from 13F filings

Historical chart of Bienville Capital Management investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Bienville Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Bienville Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $572k 58k 9.86
2023-09-30 $444k 58k 7.65
2023-06-30 $425k 57k 7.47
2023-03-31 $379k 57k 6.67
2022-12-31 $439k 57k 7.71
2022-09-30 $648k 61k 10.63
2022-06-30 $298k 37k 8.15
2022-03-31 $262k 37k 7.17
2021-12-31 $626k 37k 17.12